Previous literature suggests the association of BP with stroke risk is twice as high for participants of Asian ethnicity compared with those identifying as White,6 7 and a randomised trial of the angiotensin-converting enzyme inhibitor perindopril compared with placebo showed larger benefits among those with Asian ethnicity.8 This evidence concerns the gene ACE and stroke disorder.